Clinical Trial Detail

NCT ID NCT03181100
Title Atezolizumab Combinations With Chemotherapy for Anaplastic and Poorly Differentiated Thyroid Carcinomas
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors M.D. Anderson Cancer Center
Indications

thyroid carcinoma

Therapies

Nab-paclitaxel

Paclitaxel

Atezolizumab + Cobimetinib

Atezolizumab + Bevacizumab

Atezolizumab + Nab-paclitaxel

Atezolizumab + Cobimetinib + Vemurafenib

Atezolizumab + Paclitaxel

Age Groups: senior adult

Additional content available in CKB BOOST